Proteomic Analysis of Human Pluripotent Cells

Human Stem Cell Technology and Biology: A Research Guide and Laboratory Manual

Volumn , Issue , 2010, Pages 245-256

  Lau, Andy T Y ^a   Xu, Yan Ming ^b   Chiu, Jen Fu ^c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Embryonic stem (ES) cells, pluripotent cells from inner cell mass of blastocyst stage embryos; Proteomic analysis of human pluripotent cells; Proteomics techniques two dimensional polyacrylamide gel electrophoresis (2D PAGE)

Indexed keywords

EID: 84860603864     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470889909.ch21     Document Type: Chapter

References (53)

1. Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 2005;19:1129-1155.
2. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell. 2008;132:661-680.
3. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676.
4. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872.
5. Smith KP, Luong MX, Stein GS. Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol. 2009;220:21-29.
6. Liu N, LuM, Tian X, et al. Molecularmechanisms involved in self-renewal and pluripotency of embryonic stem cells. J Cell Physiol. 2007;211:279-286.
7. Nagano K, Yoshida Y, Isobe T. Cell surface biomarkers of embryonic stem cells. Proteomics. 2008;8:4025- 4035.
8. Sun Y, Li H, Liu Y, et al. Cross-species transcriptional profiles establish a functional portrait of embryonic stem cells. Genomics. 2007;89:22-35.
9. Zhan M. Genomic studies to explore self-renewal and differentiation properties of embryonic stem cells. Front Biosci. 2008;13:276-283.
10. CloonanN, Forrest AR, Kolle G, et al. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat Methods. 2008;5:613-619.
11. Krishna RG, Wold F. Post-translational modification of proteins. Adv Enzymol Relat Areas Mol Biol. 1993;67:265-298.
12. Kouzarides T. Chromatin modifications and their function. Cell. 2007;128:693-705.
13. Wasinger VC, Cordwell SJ, Cerpa-Poljak A, et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis. 1995;16:1090-1094.
14. Anderson NG, Anderson NL. Twenty years of twodimensional electrophoresis: past, present and future. Electrophoresis. 1996;17:443-453.
15. Wilkins MR, Sanchez JC, Gooley AA, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev. 1996;13:19-50.
16. Lau AT, He QY, Chiu JF. Proteomic technology and its biomedical applications. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003;35:965-975.
17. Blackstock WP, Weir MP. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 1999;17:121-127.
18. Lau AT, Chiu JF. Biomarkers of lung-related diseases: current knowledge by proteomic approaches. J Cell Physiol. 2009;221:535-543.
19. Lau AT, He QY, Chiu JF. A proteome analysis of the arsenite response in cultured lung cells: evidence for in vitro oxidative stress-induced apoptosis. Biochem J. 2004;382:641-650.
20. Zhou Y, Bhatia I, Cai Z, et al. Proteomic analysis of neonatal mouse brain: evidence for hypoxia- and ischemia-induced dephosphorylation of collapsin response mediator proteins. J Proteome Res. 2008;7:2507-2515.
21. Unlu M, Morgan ME,Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis. 1997;18:2071-2077.
22. Perkins DN, Pappin DJ, Creasy DM, et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20:3551-3567.
23. Zhang W, Chait BT. ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem. 2000;72:2482-2489.
24. Clauser KR, Baker P, Burlingame AL. Role of accurate mass measurement (± 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal Chem. 1999;71:2871-2882.
25. James P, QuadroniM, Carafoli E, et al. Protein identification by mass profile fingerprinting. Biochem Biophys Res Commun. 1993;195:58-64.
26. Mann M, Hojrup P, Roepstorff P. Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol Mass Spectrom. 1993;22:338-345.
27. Pappin DJ, Hojrup P, Bleasby AJ. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol. 1993;3:327-332.
28. Yates JR 3rd, Speicher S, Griffin PR, et al. Peptide mass maps: a highly informative approach to protein identification. Anal Biochem. 1993;214:397-408.
29. Jensen ON, Podtelejnikov AV, Mann M. Identification of the components of simple protein mixtures by high-accuracy peptide mass mapping and database searching. Anal Chem. 1997;69:4741-4750.
30. Canas B, Lopez-Ferrer D, Ramos-Fernandez A, et al. Mass spectrometry technologies for proteomics. Brief Funct Genomic Proteomic. 2006;4:295-320.
31. Clayton AL, Rose S, Barratt MJ, et al. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. EMBO J. 2000;19:3714-3726.
32. Garcia BA, Barber CM, Hake SB, et al. Modifications of human histone H3 variants during mitosis. Biochemistry. 2005;44:13202-13213.
33. Fung ET, Thulasiraman V, Weinberger SR, et al. Protein biochips for differential profiling. Curr Opin Biotechnol. 2001;12:65-69.
34. McCormack AL, Schieltz DM, Goode B, et al. Direct analysis and identification of proteins in mixtures by LC/MS/MS and database searching at the low-femtomole level. Anal Chem. 1997;69:767-776.
35. Peng J, Gygi SP. Proteomics: the move to mixtures. J Mass Spectrom. 2001;36:1083-1091.
36. Gygi SP, Rist B, Gerber SA, et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17:994-999.
37. Haynes PA, Yates JR 3rd. Proteome profiling-pitfalls and progress. Yeast. 2000;17:81-87.
38. Ong SE, Blagoev B, Kratchmarova I, et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1:376-386.
39. Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using aminereactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154-1169.
40. Ivanovic Z. Hypoxia or in situ normoxia: the stem cell paradigm. J Cell Physiol. 2009;219:271-275.
41. Yoshida Y, Takahashi K, Okita K, et al. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell. 2009;5:237-241.
42. Baharvand H, Hajheidari M, Ashtiani SK, et al. Proteomic signature of human embryonic stem cells. Proteomics. 2006;6:3544-3549.
43. Schulz TC, Swistowska AM, Liu Y, et al. A large-scale proteomic analysis of human embryonic stem cells. BMC Genomics. 2007;8:478.
44. Yocum AK, Gratsch TE, Leff N, et al. Coupled global and targeted proteomics of human embryonic stemcells during induced differentiation. Mol Cell Proteomics. 2008;7:750-767.
45. Dormeyer W, vanHoof D, Braam SR, et al. Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells. J Proteome Res. 2008;7:2936-2951.
46. ProkhorovaTA, RigboltKT, JohansenPT, et al. Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol Cell Proteomics. 2009;8:959-970.
47. Lim JW, Bodnar A. Proteome analysis of conditionedmedium from mouse embryonic fibroblast feeder layers which support the growth of human embryonic stem cells. Proteomics. 2002;2:1187-1203.
48. Chin AC, Fong WJ, Goh LT, et al. Identification of proteins from feeder conditioned medium that support human embryonic stem cells. J Biotechnol. 2007;130:320-328.
49. Prowse AB, McQuade LR, Bryant KJ, et al. Identification of potential pluripotency determinants for human embryonic stem cells following proteomic analysis of human and mouse fibroblast conditioned media. J Proteome Res. 2007;6:3796-3807.
50. Levenstein ME, Berggren WT, Lee JE, et al. Secreted proteoglycans directly mediate human embryonic stem cell-basic fibroblast growth factor 2 interactions critical for proliferation. Stem Cells. 2008;26:3099-3107.
51. Swaney DL,Wenger CD, Thomson JA, et al. Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci USA. 2009;106:995-1000.
52. Brill LM, Xiong W, Lee KB, et al. Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell. 2009;5:204-213.
53. Van Hoof D, Munoz J, Braam SR, et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell. 2009;5:214-226.